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This report details the outcome of the 2nd Hospital Microbiome Project workshop held on 
January 15th at the University of Chicago, USA. This workshop was the final planning meeting 
prior to the start of the Hospital Microbiome Project, an investigation to measure and charac-
terize the development of a microbial community within a newly built hospital at the Univer-
sity of Chicago. The main goals of this workshop were to bring together experts in various 
disciplines to discuss the potential hurdles facing the implementation of the project, and to 
allow brainstorming of potential synergistic project opportunities. 
The Hospital Microbiome Project 
572 Standards in Genomic Sciences 
Introduction In the United States, nearly 5% of all patients ad-mitted to a medical facility will be diagnosed with a hospital-acquired infection [1]. These infections cost an estimated 36 - 45 billion dollars annually [2] and result in approximately 100,000 deaths annually [3]. While these numbers are concerning, they highlight a considerable lack of evidence re-garding both the source and development of noso-comial infections. The Hospital Microbiome Pro-ject (HMP) was created to characterize the taxo-nomic composition of surface-, air-, water-, and human- associated microbial communities at a newly constructed University of Chicago Medical Center Hospital in Chicago, Illinois, USA, also known as the Center for Care and Discovery (CCD) [4]. The aim of the HMP is to sample the building, patients, and staff in a systematic, coordinated ap-proach over the course of one year (January 2013 - January 2014), specifically incorporating build-ing science measurements to determine their in-fluence on the development of microbial commu-nities, with sampling starting one month prior to the opening of the new hospital (February 23rd 2013). The 1st HMP Workshop was held June 7th-8th 2012 to address the initial sampling strategy and ap-proach to building science measurements. This initial workshop made several recommendations and led to the development of a full proposal to the Alfred P. Sloan Foundation as well as to the creation of the Hospital Microbiome Consortium [5]. The final proposal was funded and imple-mented in December 2012. Here we present discussion and conclusions from the 2nd HMP Workshop held on January 15th, 2013 at the University of Chicago, in Chicago, Illinois, USA. The goals of this workshop were to bring to-gether experts in various disciplines to discuss the current hurdles faced in characterizing interaction between human microbiomes and building sur-faces and to consider potential strategies to mini-mize the transmission of infection diseases within hospitals. The group was comprised of architects, building scientists, and building systems engi-neers, as well as project managers, medical staff, hospital management, microbiologists, microbial ecologists, virologists, epidemiologists, and stand-ards officials. This represented the last formal or-ganizational meeting prior to the start of sample collection (January 16th 2013). Ample time was also spent brainstorming synergistic project op-
portunities asking ‘how can the HMP data set complement other studies and how can other studies be incorporated into the HMP?’ The meeting occurred over one day, starting at 9am and ending after dinner at 9pm. The format consisted of two formal presentations with ample time for subsequent discussion; this forum was successful in engaging the research community at the meeting and providing valuable feedback to the project management team. These more formal sessions were complemented by introductions of all meeting participants with an opportunity for each participant to informally describe their in-terest in the HMP and potential areas for possible synergistic investigations. 
Meeting Participants John Alverdy MD: Department of Surgery, University of Chicago, USA Gary An MD: Department of Sur-gery, University of Chicago, USA Seema Bhangar PhD: Department of Civil and Environmental Engi-neering, University of California Berkeley, USA Eugene B. Chang MD: Department of Medicine, University of Chicago, USA Sarah Cobey PhD: Department of Ecology and Evolution, University of Chicago, USA Betsy Foxman PhD: Department of Epidemiology, University of Michi-gan School of Public Health, USA Jack Gilbert PhD: Argonne National Laboratory, USA; Department of Ecology and Evolution, University of Chicago, USA Mark Hernandez PhD: Department of Environmental Engineering, Uni-versity of Colorado, USA Rachael M. Jones PhD: School of Public Health, University of Illinois at Chicago, USA 
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Kevin Keegan: Argonne National Laboratory, USA Scott T. Kelley PhD: Department of Biology, San Diego State University, USA Benjamin Kirkup PhD: Department of Wound Infections, Walter Reed Army Institute of Research, USA Emily Landon MD: Department of Medicine, Infection Control, Uni-versity of Chicago, USA Hal Levin PhD: Building Ecology Research Group, USA Michael Morowitz MD: Department of Surgery, University of Pittsburgh, USA Paula Olsiewski: Alfred P Sloan Foundation, USA. Aaron Packman PhD: Department of Civil and Environmental Engi-neering Northwestern University, USA Joan Suchomel: Skidmore, Owings & Merrill LLP, USA Jeffrey Siegel PhD: Department of Civil Engineering, University of To-ronto, Canada Daniel Smith PhD: Institute for Ge-nomic and Systems Biology, Ar-gonne National Laboratory, USA Brent Stephens PhD: Department of Civil, Architectural and Environ-mental Engineering, Illinois Insti-tute of Technology, USA Mariana Rosenthal MPH, PhD: De-partment of Epidemiology, Univer-sity of Michigan School of Public Health, USA Gary Vora PhD: Center for Bio/Molecular Science and Engi-neering, Naval Research Laborato-ry, USA 
Stephen Weber MD: Chief Medical Officer, University of Chicago, USA Ann Womack: Biology and the Built Environment Center, Institute of Ecology and Evolution, University of Oregon, USA 
Session 1: Overview of the Hospital 
Microbiome Project 
Moderated by Jack Gilbert, PhD The meeting began with an introduction by pro-ject principal investigator Jack Gilbert Ph.D. Jack provided an overview of what he hoped to gain from this meeting. He highlighted the multidisci-plinary nature of the project, and applauded the University of Chicago and the management and staff of the new Center for Care and Discovery for helping to pioneer a project, which could have such a revolutionary impact on patient care in hospitals across the globe. He briefly outlined the rationale for the HMP, which is to create a ‘roadmap’ of microbial transmission routes and succession within the hospital infrastructure, to provide researchers with the most detailed explo-ration of microbial colonization of a new hospital ever under taken. He also thanked the Alfred P Sloan Foundation and his co-convener Capt Ben-jamin Kirkup for providing the appropriate re-sources and support needed for the meeting to take place. He thanked his fellow Co-PIs for their support on this award, and the attendees and members of the HMP Consortium for making time to help guide and influence the HMP study design. Finally, he highlighted that while sampling would commence the very next day, everything was still on the table, and having the hospitals Infection and Immunity staff at the meeting would enable vital discussions of technical and political feasibil-ity for any and all suggestions that were raised at the meeting. 
Session 2: Approaches and findings of 
ongoing microbiome studies 
Moderated by Daniel Smith PhD Daniel Smith Ph.D. began this session by reinforc-ing the rationale, presenting existing microbiome data on hospital surfaces and patients, and then discussing the current protocol for the HMP. The existing protocol can be found online at the hospi-tal microbiome website [6] where the full details of the study are provided. Daniel provided an 
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overview of the core hypotheses for the HMP, which were discussed extensively, and found to be appropriate for guiding the research outlined in the existing proposal. 
The core hypotheses were: 1. Microbial community structure on 
hospital surfaces can be predicted 
by human demographics, physical 
conditions (e.g. humidity, temper-
ature), and building materials for 
each location and time. The null-hypothesis states that “microbial community structure exists in-dependently of human interac-tion and physical conditions of the built system”. While this hy-pothesis has been tested in dif-ferent environments, the current study will be testing it to deter-mine if defined relationships ex-ist that could help predict the succession of microbial commu-nities, including potential patho-gen reservoirs. Sampling will al-so be acquired from the health care workers who frequent the patient room to determine if they are vectors in bacterial community formation. 2. A patient-room microbiota is in-
fluenced by the current patient 
and their duration of occupancy, 
and shows community succession 
with the introduction of a new oc-
cupant. The null-hypothesis states that “the patient’s interac-tion with a room has little impact on microbial community struc-ture on the surfaces of that room, and this relationship is not changed by duration of occupan-cy”. The duration of occupancy for patients in this new hospital will vary considerably. The ex-perimental design will focus on two different modes, oncology (floor 10) will have long resi-
dence times of >2-3 weeks, while surgery (floor 9) will have short residence times of <3 days on average. By monitoring 5 patient rooms on these two floors at dif-ferent temporal scales (daily and weekly) it will be possible to de-termine the impact of the pa-tient’s occupancy on the compo-sition and structure of the mi-crobial communities in the room. 3. The colonization of the surfaces 
and patients by potential patho-
gens is influenced by composition 
and diversity of the existing mi-
crobial community derived from 
previous occupants of the space. The null-hypothesis states, “Ex-isting microbial communities as-sociated with a surface do not in-fluence the colonization, succes-sion or development of a new community”. Validation of the hypothesis would indicate that existing microbial communities could be useful in altering the development of new, potentially pathogenic, organisms on a sur-face. This will be vitally im-portant in determining how mi-crobes interact in this complex, dynamic system, and how we can potentially change the para-digm view of bacteria in a hospi-tal, in that some may be benefi-cial to a healthy environment. 4. The rate of microbial succession is 
driven by demographics, usage 
and building materials. The null-hypothesis states “community structure and composition evolves independently of human population demographics and occupancy and of the building materials used to construct the room and surfaces”. This hy-pothesis explicitly focuses on the rate of succession of the com-
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munity, and will be explored by comparing different temporal resolutions of observation, and defining how rapidly communi-ties change on different surfaces, and in rooms with different pa-tient, and health-care worker turnover rates. Subsequent discussion began by exploring the po-tential dynamics governing the development of the microbiome in patient rooms. Initially, the time between occupancy of the patient rooms was discussed with regard to the role this may play in the formation of the room microbiome. Seema Bhangar reviewed work done in classrooms show-ing that occupancy produced very dynamic chang-es in levels of airborne biological particles (in a study where laser- induced fluorescence was used as an indicator of biological origin) [7]. She de-scribed that when people enter a room, there is an immediate spike in airborne levels of large (1-15 micron) total and fluorescent biological airborne particles. Pronounced changes in the airborne sig-nal are observed during cleaning, and with the change in operational state (off vs. on) of a me-chanical ventilation system. Emily Landon, an ex-pert in infectious disease, noted that hospital cleaning regimens are not always identical be-tween rooms, and therefore, which regimen was used needs to be recorded. She also stated that all aspects of the cleaning regime, including chemi-cals and products used, would be made available to the investigators. Additionally, a ‘timestamp’ of when the cleaning occurred will be provided, as well as the duration of time elapsed between room cleanings. Knowing that surface material has a large influence on the composition of microbial flora, Michael Morowitz suggested that recording building material might also be beneficial in help-ing describe the formation of microbial communi-ties on surfaces; this was flagged, and the details of the building materials were to be made availa-ble for databasing. The conversation then turned to possible contam-ination issues. Hal Levin, from the Building Ecolo-gy Research Group, described the need to differen-tiate outdoor from indoor air, even if the outdoor air is filtered. Another concern, expressed by Emi-ly Landon, is the potential contamination by dust residing on the air filter apparatus. Brent Ste-phens suggested that the use of a particle sampler would be helpful in determining the amount of 
outside air and dust contamination. Emily also suggested that patient visitors might have a poten-tial impact on the microbial content of patient rooms, although she noted that there is no pub-lished evidence of a direct link between hospital attendance and disease acquisition, only circum-stantial evidence. John Alverdy suggested that the HMP is in a unique position to be able to prove or disprove the link between hospital attendance and patient disease. It was noted, though, that pin-pointing exactly how a patient or hospital worker acquired a bacterial infection might impose a lia-bility. For example, Emily points out that in the Netherlands, healthcare workers are banned from working if they screen positive for methicillin-resistant Staphylococcus aureus (MRSA). Although this has reduced the rates of MRSA in the Nether-lands, it presents a possible conflict between the HMP and the hospital staff, potentially limiting recruitment [8]. Lastly, there was discussion on sample acquisi-tion. Benjamin Kirkup pointed out that currently the way in which we determine infectious agents (i.e. culture of microbes followed by biochemical virulence testing) ignores the vast majority of the microbial world. The HMP using 16S, 18S, and ITS rDNA amplicon sequencing has the potential to produce valuable insight into defining the entire microbial community in each sample, although as noted in the meeting, there are no universal pri-mers [9]. Eugene Chang additionally questioned how the role of viruses would be defined? This highlights a significant problem in most ecological experiments and observations involving microbial communities, which is the lack of understanding of the role viruses play in the dynamics observed for these communities. The problem is that there is no single gene that can be used as a ‘universal’ marker to capture the diversity of phage as they infect and ‘control’ microbial populations. There-fore, the only immediate solution is to either tar-get the analysis and search in the light of current knowledge, or develop techniques to use metagenomic sequencing with enriched viral samples. Jack Gilbert highlighted ongoing work by Scott Kelley to define virus sampling and observa-tion protocols using metagenomics, including data being generated at the current time, and suggest-ed that these will be applied where appropriate to the HMP samples to try and examine how phage are changing bacterial community dynamics in these settings. A singular concern is actually ob-taining enough viral particles to obtain enough 
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DNA, as well as how we deal with DNA vs RNA vi-ruses in analysis. Scott Kelley discussed some techniques he is currently working on to address these concerns, however, he also explained that these were not yet published. Emily Landon ex-pressed concern about examining viruses at all, by voicing the common notion that hospitals do a rel-atively good job disinfecting viruses; however, Gary An questioned ‘how can the hospital do an adequate job of viral disinfection if they do not know what they are looking for?’ Hence, it was agreed that exploring a method for describing vi-ral populations was needed and could potentially be a major NIH proposal to utilize the HMP sam-ples. Mariana Rosenthal, an epidemiologist from the University of Michigan, alerted the group to the potential biases resulting from choice of sampling methods. For example, hand swabs will likely yield different results from the glove-juice meth-od, whereby the hand is placed in a buffer-containing sterile bag, and massaged for a minute. Swab sample collection efficiencies may depend upon the swab material and swab composition used, the surface type, and how the investigator swabs the surface of interest. It was suggested that videos of the sampling could be made for both training investigators and for exploring variance. Further, it was proposed that during data analysis, a sampling treatment bias analysis be part of the standardization effort. It was finally discussed that while glove-juice, tissue punches and scrapes were absolutely more effective at isolating com-munity information from skin samples, there were certain impracticalities to applying these tech-niques repeatedly for thousands of samples, and with sampling done every day, the ability of exist-ing personnel to carry out this initiative would be limited. Therefore, for the time being vigorous skin swabbing was upheld as an appropriate strategy. However, the potential to examine the glove-juice method in the context of the HMP was not disregarded, and was in fact encouraged, so that an accessory study was discussed. 
Session 3: Potential litigation issues 
with hospital research 
Moderated by Stephen Weber MD Stephen Weber MD, an expert in infectious dis-ease, clinical quality and patient safety, and the Chief Medical Officer of the University of Chicago Medical Center presented his view of the HMP. 
First, Dr. Weber expressed his great excitement for both the development of HMP and the geo-graphic home for the HMP being the University of Chicago Medical Center. As a hospital administra-tor, Dr. Weber discussed the potential litigation issues of conducting hospital-based research and performance improvement in Cook County, one of the most litigious areas of the country. He de-scribed the Illinois Medical Studies Act (735 ILCS 5/8-2101), a law that defines the appropriate management of data and documents, allowing protection from litigation in support of perfor-mance improvement and quality activities. The intent of the law is to encourage clinicians and in-vestigators to engage in free discussion and inves-tigation to improve patient care. Despite this, Dr. Weber stressed the importance of putting in place safeguards when collecting and managing patient data to protect patient confidentiality. 
Session 4: Public perspective on the HMP 
Moderated by Emily Landon MD Emily Landon led a discussion on the public per-spective on the HMP noting the common public notion that microbes are bad, and that we should work towards total disinfection. It was suggested that the HMP has the potential to educate the pub-lic, and show microbial ecology in a new light. Yet, due to the potential risk that the public will view this investigation as negative (i.e., microbes are bad and the hospital is dirty), we must be ex-tremely careful in how we disseminate our find-ings. It was discussed that with the help of infec-tion control groups, ethicists, legal teams, and the HMP consortium, guidelines need to be developed that will help translate the data to the public in a positive light. Overall, the group agreed that an important goal of the HMP should be to provide public education about microbial ecology and how this project may relate to human health and dis-ease. 
Session 5: Meeting participant introductions 
and brainstorming The final session was designed to provide an op-portunity for open discussion and brainstorming. Each participant was given ample time to describe potential synergistic project opportunities relating to their specific area of expertise. Below is a sum-mary of the main discussion points raised by each participant: 
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Eugene Chang MD: As a physician scientist, Eugene Chang wanted to use the HMP to explore how mi-crobes impact health, and how humans influence microbes. He is especially interested in Clostridi-
um difficile infection, a common nosocomial infec-tion of the intestine, and questions if C. difficile is present in the gut microbiome of every patient, even if at low abundance, which would allow the pathogen to emerge given a specific microenvi-ronment? 
Gary An MD: Gary An, a surgeon and computation-al biologist, was interested in how hospital ac-quired infections occur, and how ecological forces influence microbial pathogenesis. He discussed the potential of agent based modeling of these forces to gain insight into the dynamics that gov-ern microbial ecology. 
Jeffrey Siegel PhD: As an architectural and envi-ronmental engineer Jeffrey Siegel was interested in looking at the structural parameters of the building itself that influence microbes, and deeply exploring this complex relationship. 
Hal Levin: As a research architect, Hal Levin sug-gested that the chemistry on surfaces was vital to understanding the development of microbial communities. Biological interaction with a surface will both be influenced by and will influence this chemistry. 
Michael Morowitz MD: Michael Morowitz com-mented that the microbiome is going play a pivot-al role as we enter the era of personalized medi-cine. He has designed a NICU microbiome study and would like to compare his data to this hospital study. These studies allow us to introduce whole genome sequencing to monitor evolutionary de-velopment of the microbiome in these various sys-tems. 
Benjamin Kirkup PhD: Captain Benjamin Kirkup runs the US Army hospital microbiome analysis, which is a sister study of the core HMP. He dis-cussed Acinetobacter infection in soldiers, and how, by using swabs of patients, they investigated bacterial spreading patterns [10]. Results demon-strated that the source of Acinetobacter was from local nationals, who after interacting with soldiers at field hospitals, infected soldiers. He is now in-terested in potential routes of transmission in the hospitals, especially hospitals where patients have exceptional, vulnerable wounds. He also suggested the use of auto-fluorescent particle monitoring in which healthcare professionals add the trackable 
particle to a surface and then monitor its move-ment around a system. 
Joan Suchomel: As an architect, she is interested in how building design directly affects patients. 
Scott T. Kelley PhD: As a biologist, Scott Kelley dis-cussed his interest in the office, NICU, and viral microbiome. His research focuses on investigating the presence of plasmid and free DNA leading to antibiotic resistance. 
John Alverdy MD: A surgeon scientist, he has iden-tified the molecular pathways by which microbes sense host stress, which in turn activates viru-lence circuitry increasing pathogenicity. He is very interested in the HMP citing, that there is little ev-idence as to why patients get infected in hospitals. Seema Bhangar PhD: Deploying real time instru-ments to measure particles and occupancy, to ob-tain insight into the role of human activities in the release and spread of particles (including mi-crobes) in a NICU. A central challenge is designing an instrument case that meets the hospital’s con-straints. 
Gary Vora PhD: As a molecular microbiologist and co-developer of the Antimicrobial Resistance De-terminant Microarray (ARDM), Gary Vora was in-terested in testing the HMP sample collection us-ing the ARDM as a surveillance tool to establish the baseline of drug resistance genes in this envi-ronment. He felt that when this data was integrat-ed with the many other data types that are to be generated from within the HMP, it would provide a unique opportunity to identify potential reser-voirs of antimicrobial resistance and monitor the evolution of drug resistance and multidrug re-sistant genetic assemblages over time and space. 
Rachael Jones PhD: Rachael Jones, an expert in ex-posure science and microbial risk assessment, is interested in using the HMP data to understand how microbes move through the hospital envi-ronment, and impact infection risk for health care workers. 
Kevin P. Keegan PhD: Kevin Keegan, an expert in bioinformatic statistics, was interested in making sure that sampling was robust enough to pick out correlations of interest; even if individual data points/modules (e.g. faulty air sampling in a room) have to be culled. The replicated design that is currently in place addresses these issues. Kevin is also interested in applying and/or devel-oping statistical analyses that will take full ad-vantage of the robust sampling regimen to tease 
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out gross and subtle correlations between various hospital environments and the evolving composi-tion of their microbial communities. 
Mariana Rosenthal MPH, PhD: Mariana Rosenthal is interested in the hand microbiome of healthcare workers and posits ‘does the hand microbiota me-diate pathogen carriage among healthcare work-ers?’ She suggests that by using real-time qPCR from HMP samples, we will be able to determine the correlation between microbial community structure and the relative abundance of pathogen-ic taxa. 
Betsy Foxman PhD: Described the importance of colonization resistance of microbiota and suggest-ed that if the results of the HMP show that the microbiota on surfaces and hands is resilient to cleaning, then we will need to undergo further in-vestigation to determine how and why. To do this, it is imperative to preserve the swab samples to do metagenomics, metatranscriptomics, metametabolomics, and metaproteomics in the future. 
Sarah Cobey PhD: As an ecologist, Sarah Cobey fo-cuses on mathematical and statistical analyses to infer how pathogens interact with each other and with their hosts. She mentioned several approach-es to understanding the flow of microbes within the hospital system. She suggested that accurately characterizing microbial community succession and metapopulation dynamics might require more intensive sampling of healthcare workers. In addi-tion, stool samples could illuminate the transmis-sion of microbes that are potentially transmitted by the fecal-oral route. Although these kinds of intensive samplings are the ‘best case scenario,’ she noted that the protocol should not discomfort or inconvenience the subjects. 
Aaron Packman PhD: As an environmental engi-neer, Aaron Packman spoke about pathogen spread in municipal water systems, interaction of pathogen biofilms, biofilm sloughing, and biofilm detachment. He stated that we currently do not understand what impact selective pressures are having on the development of microbial diversity. He would like to do transport modeling to create bacterial network structures of connectivity with-in the hospital to determine what controls the community that persists over time. 
Mark Hernandez PhD: As an environmental micro-biologist, Mark Hernandez studies microbial par-ticle transport in liquids (i.e. air and water). He would like to sample aerosols in different envi-
ronments of the hospital, and proposed an exten-sive analysis within the CCD to compliment and augment results from the core HMP work. 
Brent Stephens PhD: Presented an overview of the building science measurements that will comple-ment the biological sampling in the hospital for this study. These measurements include active sensing and logging of patient room temperature, relative humidity, and light intensity; patient room pressurization with respect to the adjacent hallway; percentage of outdoor air delivered to each floor; and human occupancy and air ex-change rates in each patient room. Additional pas-sive measurements include aerosol sampling of patient room air for microbial analysis using par-ticle filter media covering the return HVAC grilles in each room affixed with strip magnets. The use of high- precision CO2 monitors in the central HVAC supply, return, and outdoor air streams provide an estimate of the fraction of outdoor air delivered to each floor and individual flow meas-urements in patient rooms provide an estimate of outdoor air ventilation rates in each room. The same CO2 monitors are used in the patient rooms alongside IR beam break sensors across the door-ways to measure patient room occupancy. Active data collection occurs at 5-10 minute intervals throughout the duration of the study. Obtaining these measurements necessitates working closely with building supervisors, physical plant staff, and regulatory bodies in order to install monitoring devices in the patient rooms and the mechanical floors housing the hospital’s HVAC systems. 
Wrap-Up and summary A number of key projects were identified as de-scribed above that could help to augment or sup-port the existing HMP measurements, including viral diversity measurements, increased antibiotic resistance array screening, particle transport measurements, and personnel tagging for demo-graphic movement analysis. However, the existing strategy for the core HMP remained unchallenged, with all participants agreeing that despite certain inherent biases, the resulting data would be highly appropriate for testing the specific hypothesis out-lined in the study. All participants were invited for dinner at the end of the meeting, which resulted in lively discussion regarding the potential impact of the study and the importance of continuing this research beyond the existing 2- year study. It was agreed that sources of funding should be identified 
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that could help support and augment the existing research effort. One key research project that was identified revolved around high spatial and tem-poral resolution observation of microbial and hu-man occupant dynamics. It was agreed that this would enable more specific identification of the routes of transmission between building occupants 
and building infrastructure. Aaron Packman agreed to help lead this initiative, and with Jack Gilbert and Rachael Jones, has submitted an application to the Chicago Biomedical Consortium. Emily Landon agreed to help address the IRB language and enable access to existing observational data of healthcare worker activity patterns for this effort. 
Disclaimer The opinions and assertions contained herein are the private views of the authors and are not to be  construed as official or as reflecting true views of the Department of Army or the Department of Defense. 
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